Clinical trial
Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry in Patients Receiving Allotransplantation: a Multi-center, Prospective Clinical Study
NCT06569095 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry in Patients Receiving Allotransplantation: a Multi-center, Prospective Clinical Study
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 9, 2024
- Completion date
- December 18, 2027
- Enrollment
- 163 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.